stars 1 stars 2 stars 3

We are a research-driven company that specialises in the development, manufacture and supply of a broad range of High Potency Oral Solid Dose (OSD) Human & Veterinary speciality products. Since 2006, we have built a reputation as an innovative company specialising in developing and manufacturing of film-coated tablets, soft-gel capsules, and powder or liquid-filled hard-shell capsules. Our work, which focused on successfully producing cancer chemotherapy drugs, allowed us to create strong partnerships with leading pharmaceutical companies, thus making our founders’ vision a reality. In 2015, our successful track record and reputation for industry excellence prompted the acquisition of Eirgen Pharma by the OPKO Health family of companies. Becoming a part of OPKO Health has allowed Eirgen Pharma to invest further in our facilities and our people, increasing development and manufacturing capabilities. Eirgen now serves patients in more than 60 countries worldwide, including major markets such as the USA, Europe, Japan, Canada, Australia, the Middle East and Africa. Nowadays, at Eirgen Pharma’s centre of excellence in Waterford, Ireland, we simplify the journey of getting your product to market by providing full turnkey CDMO services for the development, manufacture and packaging of high potency oral dose medicines for both human and veterinary use. Eirgen also holds the production rights for numerous OSD products and has the capacity to manufacture each of these products at scale.

View Top Employees from Eirgen Pharma
Revenue $47.4 million
Employees 169 (169 on RocketReach)
Founded 2005
Address Westside Business Park Old Kilmeaden Rd, Waterford, Munster X91 YV67, IE
Phone +353 51 591 944
JavaScript, HTML, PHP +22 more (view full list)
Category Manufacturing, Pharmaceutical Manufacturing, Manufacturing General, High Potency Pharmaceutical Products, Medical, Oncology & Cytotoxic products, Health Care, EMA, FDA & PMDA approved facility, Pharmaceutical, HIgh Containment product development & manufacture
Web Rank 4 Million
Keywords eirgen, eirgen careers, airgen, eirgen pharma
SIC 283, 28
NAICS 32541, 325, 32, 3254

Eirgen Pharma Questions

The Eirgen Pharma annual revenue was $47.4 million in 2023.

Damien Burke is the CEO of Eirgen Pharma.

169 people are employed at Eirgen Pharma.

Eirgen Pharma is based in Waterford, Munster.

The NAICS codes for Eirgen Pharma are [32541, 325, 32, 3254].

The SIC codes for Eirgen Pharma are [283, 28].

Top Eirgen Pharma Employees

How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
G2Crowd Trusted
300K+ Plugin Users